William Lavely, MD
Nuclear Medicine · Atlanta, GANPI 1164449146
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $53,936 of the $86,978 with a category attached, or 62.0%. Progenics Pharmaceuticals, Inc. accounts for 68.6% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $63,203, 5.2 times the $12,214 reported in 2019.
Across 81 payments — averaging $1073.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Progenics Pharmaceuticals, Inc.$60K
- Medivation LLC.$19K
- Blue Earth Diagnostics$5K
- Telix Pharmaceuticals$4K
- Pfizer$210
- Advanced Accelerator Applications$125
- plus $86 from 3 others
Across 21 payments — averaging $22,498 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Hoffmann-la Roche Limited$260K
- Blue Earth Diagnostics$212K
What the payments were for
- Consulting fees$26,84331%
- Speaking & faculty fees$53,93662%
- Travel & lodging$4,9806%
- Food & beverage$1,2201%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Progenics Pharmaceuticals, Inc. | 39 | $59,696 |
| Medivation LLC. | 23 | $18,520 |
| Blue Earth Diagnostics | 10 | $4,741 |
| Telix Pharmaceuticals | 3 | $3,600 |
| Pfizer | 1 | $210 |
| Advanced Accelerator Applications | 1 | $125 |
| Cardinal Health 414 LLC | 2 | $41 |
| Curium US LLC | 1 | $33 |
| Novartis | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few nuclear medicine providers in Georgiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nuclear medicine in Atlanta
- Roderic PettigrewAtlanta$67K
- Charles MarcusAtlanta$1K
- Ila SethiAtlanta$507
- Tyrel FosterAtlanta$220
- Valeria MoncayoAtlanta$165
- Imad AbossallueAtlanta$153
- Lance HallAtlanta$0
- Bruce BarronAtlanta$0
- Naomi AlazrakiDecatur$191
- Hadyn WilliamsAugusta$98
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.